/ /

Cheryl Guttman Krader
Can an intracameral mydriatic combination reduce need for pupil expanders?
Intracameral administration of the fixed combination of phenylephrine and ketorolac injection 1%/0.3% (Omidria, Omeros) during cataract surgery is safe and effective for maintaining pupil dilation, and minimizes the need for a pupil expansion device, according to the findings of a retrospective study conducted by Frank A. Bucci, Jr., MD.
New-generation presbyopia-correcting IOL
The U.S. IDE clinical trial of the investigational extended range of vision IOL (Model ZXR00; Tecnis Symfony Extended Range of Vision IOL, Abbott Medical Optics) found that the implant delivered a full range of uncorrected vision and minimized or eliminated the need for spectacle wear in most patients.
Increasing IOL power prediction accuracy
In a multicenter trial including 162 eyes undergoing cataract surgery with implantation of a variety of IOL types, use of intraoperative aberrometry to guide IOL spherical power selection minimized residual refractive error.
Complicated cataract: A case of iatrogenic zonular disinertion
An approach is described for completing cortex removal and IOL implantation after intraoperative 180° zonular dialysis.
Strategies may eliminate issues impeding Tunisian pediatric care
Delayed patient presentation, compounded by problems relating to insufficient resources and lack of follow-up, explain why pediatric cataract remains an important cause of visual impairment in Tunisia.
Wavefront-guided PRK after CXL for keratoconus
Technique targets the main cause of vision degradation and a large clinical series finds positive results.
Prolonged PROM, labor induction, and cesareans
A study looked at the outcomes for women who had prolonged premature rupture of membranes at term.
How to succeed in today's glaucoma brave new world
If clinicians understand the current state of affairs and what lies ahead, they will be able to better manage the odds of glaucoma in an era of changing health-care delivery. Andrew G. Iwach, MD, provided a snapshot of the current landscape and where the field is headed.
Numerous issues underlie unexplainable glaucoma progression
When glaucoma is progressing despite good intraocular pressure control, clinicians should consider a variety of issues before advancing patients along the therapeutic ladder.
Treating presbyopia with an eye drop?
A topical treatment that breaks apart disulfide bonds between crystalline lens proteins was shown to increase accommodative amplitude and improve near visual acuity in a randomized, placebo-controlled clinical trial.


View Results